Ebastine Teva 20 mg orodisp. tabl.

Nazione: Belgio

Lingua: inglese

Fonte: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Principio attivo:

Ebastine 20 mg

Commercializzato da:

Teva Pharma Belgium SA-NV

Codice ATC:

R06AX22

INN (Nome Internazionale):

Ebastine

Dosaggio:

20 mg

Forma farmaceutica:

Orodispersible tablet

Composizione:

Ebastine 20 mg

Via di somministrazione:

Oral use

Area terapeutica:

Ebastine

Dettagli prodotto:

CTI code: 390634-08 - Pack size: 100 - Commercialisation status: YES - FMD code: 05407003822021 - CNK code: 2929248 - Delivery mode: Medical prescription; CTI code: 390634-04 - Pack size: 30 - Commercialisation status: YES - FMD code: 05407003822007 - CNK code: 2929222 - Delivery mode: Medical prescription; CTI code: 390634-05 - Pack size: 40 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 390634-06 - Pack size: 50 - Commercialisation status: YES - FMD code: 05407003822014 - CNK code: 2929230 - Delivery mode: Medical prescription; CTI code: 390634-07 - Pack size: 98 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 390634-01 - Pack size: 10 - Commercialisation status: NO - CNK code: 2929214 - Delivery mode: Medical prescription; CTI code: 390634-02 - Pack size: 15 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 390634-03 - Pack size: 20 - Commercialisation status: NO - Delivery mode: Medical prescription

Stato dell'autorizzazione:

Commercialised: Yes

Data dell'autorizzazione:

2011-04-15